Stay in the know
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead
The Herbert Smith Freehills team was led by Dubai Partner Danila Logofet, supported by a team in London comprising partner David D'Souza, partner and co-head of Venture and Growth Capital (EMEA & America) Dylan Doran Kennett, senior associate Matthew Gallagher and associate Joshua Avis.
Partner Danila Logofet said: 'It has been a privilege to assist Bioniq and its founder in this exciting stage in the company's journey. The funding round has strategically positioned the company to embark upon its next stage of growth and to consolidate upon the back of its success to date. By assisting this leading business in what is proving to be an exciting and dynamic time for the industry, we have displayed our strength in the AI and health-tech sectors, as well as the depth and reach of our international network.'
Partner, Riyadh and Middle East
Partner, Head of Venture and Growth Capital, EMEA, London
For further information on this news article, please contact:
Communications Manager
London
Herbert Smith Freehills Kramer’s quarterly review of private capital buyouts, fundraising and disputes tells a familiar story for the first half of 2026: …
Herbert Smith Freehills Kramer has advised Aura Consolidated Group, Inc. on its acquisition of Qoria Limited, the Australian aspects of a US$100 million …
Herbert Smith Freehills Kramer has successfully represented Roland Europe Group Limited and Roland Corporation (Roland) in the dismissal of an …
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead